DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,142,000 | +7.8% | 6,511 | -0.3% | 0.28% | -2.5% |
| Q3 2021 | $1,987,000 | +13.1% | 6,529 | -0.2% | 0.28% | +19.9% |
| Q2 2021 | $1,757,000 | +13.5% | 6,545 | -4.8% | 0.24% | +10.8% |
| Q1 2021 | $1,548,000 | +0.8% | 6,876 | -0.5% | 0.21% | -4.1% |
| Q4 2020 | $1,535,000 | +3.0% | 6,910 | -0.3% | 0.22% | -4.7% |
| Q3 2020 | $1,491,000 | +20.9% | 6,928 | -0.6% | 0.23% | +15.9% |
| Q2 2020 | $1,233,000 | +27.0% | 6,972 | -0.7% | 0.20% | +13.6% |
| Q1 2020 | $971,000 | -13.8% | 7,018 | -4.3% | 0.18% | +15.7% |
| Q4 2019 | $1,126,000 | +6.1% | 7,336 | -0.2% | 0.15% | 0.0% |
| Q3 2019 | $1,061,000 | +29.4% | 7,349 | +28.2% | 0.15% | +30.8% |
| Q2 2019 | $820,000 | +5.9% | 5,734 | -2.2% | 0.12% | +11.4% |
| Q1 2019 | $774,000 | +16.9% | 5,865 | -8.7% | 0.10% | +5.0% |
| Q4 2018 | $662,000 | -5.7% | 6,422 | -0.6% | 0.10% | +6.4% |
| Q3 2018 | $702,000 | +30.0% | 6,462 | +18.2% | 0.09% | +23.7% |
| Q2 2018 | $540,000 | -10.4% | 5,469 | -11.2% | 0.08% | -8.4% |
| Q1 2018 | $603,000 | -3.4% | 6,162 | -8.3% | 0.08% | +6.4% |
| Q4 2017 | $624,000 | -6.7% | 6,718 | -14.0% | 0.08% | -4.9% |
| Q3 2017 | $669,000 | -39.6% | 7,809 | -40.6% | 0.08% | -39.7% |
| Q2 2017 | $1,108,000 | -42.4% | 13,136 | -41.6% | 0.14% | -41.9% |
| Q1 2017 | $1,924,000 | -23.9% | 22,501 | -30.7% | 0.23% | -23.3% |
| Q4 2016 | $2,529,000 | +0.9% | 32,491 | +1.6% | 0.30% | -2.2% |
| Q3 2016 | $2,506,000 | -16.7% | 31,966 | +7.3% | 0.31% | -15.9% |
| Q2 2016 | $3,009,000 | +1.0% | 29,784 | -5.1% | 0.37% | -4.9% |
| Q1 2016 | $2,978,000 | – | 31,393 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |